Monitoring and dose adjustment of regional citrate anticoagulation for continuous renal replacement therapy

PURPOSE OF REVIEW: Regional citrate anticoagulation (RCA) is the preferred anticoagulation strategy for many patients receiving continuous renal replacement therapy (CRRT). Safe implementation requires a coordinated prescription integrating citrate delivery, citrate removal within the extracorporeal circuit, individualized calcium replacement, CRRT fluid composition, and structured biochemical monitoring. This review summarizes practical approaches to RCA prescription, monitoring, and dose adjustment, emphasizing recent advances in citrate kinetics, calcium homeostasis, impaired citrate metabolism, metabolic complications, and systems-based safety. RECENT FINDINGS: Randomized trials and meta-analyses continue to demonstrate that RCA prolongs circuit life and reduces bleeding compared with systemic heparin anticoagulation, although a mortality benefit has not been demonstrated. Recent studies have refined understanding of citrate dose, systemic citrate load, first-pass citrate extraction, individualized calcium replacement based on anticipated effluent calcium losses, and recognition of impaired citrate metabolism. They also support baseline ionized calcium assessment before CRRT initiation, integration of lactate trends into assessment of citrate metabolism, individualized CRRT fluid selection, and distinguishing true citrate accumulation from other metabolic effects of RCA. SUMMARY: RCA is most effectively managed as an integrated CRRT prescription in which citrate delivery and removal, individualized calcium replacement, CRRT fluid composition, and operational parameters are coordinated to optimize circuit anticoagulation while maintaining electrolyte and acid-base homeostasis. Prescription adjustment should focus on four recurring clinical scenarios: inadequate circuit anticoagulation, negative calcium balance, excessive bicarbonate generation from citrate metabolism, and impaired citrate metabolism. Standardized protocols, structured monitoring, staff training, and workflow integration remain central to safe RCA implementation.

Authors

Institutions

Publication Details

Journal
Current Opinion in Critical Care
Published
2026-09-18
DOI
https://doi.org/10.1097/mcc.0000000000001433
Primary Topic
Acute Kidney Injury Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Monitoring and dose adjustment of regional citrate anticoagulation for continuous renal replacement therapy

Balázs Szamosfalvi, Ashita Tolwani, Lenar Yessayan
Current Opinion in Critical Care
Acute Kidney Injury Research
article

Monitoring and dose adjustment of regional citrate anticoagulation for continuous renal replacement therapy

Balázs Szamosfalvi, Ashita Tolwani, Lenar Yessayan
article en

Abstract

PURPOSE OF REVIEW: Regional citrate anticoagulation (RCA) is the preferred anticoagulation strategy for many patients receiving continuous renal replacement therapy (CRRT). Safe implementation requires a coordinated prescription integrating citrate delivery, citrate removal within the extracorporeal circuit, individualized calcium replacement, CRRT fluid composition, and structured biochemical monitoring. This review summarizes practical approaches to RCA prescription, monitoring, and dose adjustment, emphasizing recent advances in citrate kinetics, calcium homeostasis, impaired citrate metabolism, metabolic complications, and systems-based safety. RECENT FINDINGS: Randomized trials and meta-analyses continue to demonstrate that RCA prolongs circuit life and reduces bleeding compared with systemic heparin anticoagulation, although a mortality benefit has not been demonstrated. Recent studies have refined understanding of citrate dose, systemic citrate load, first-pass citrate extraction, individualized calcium replacement based on anticipated effluent calcium losses, and recognition of impaired citrate metabolism. They also support baseline ionized calcium assessment before CRRT initiation, integration of lactate trends into assessment of citrate metabolism, individualized CRRT fluid selection, and distinguishing true citrate accumulation from other metabolic effects of RCA. SUMMARY: RCA is most effectively managed as an integrated CRRT prescription in which citrate delivery and removal, individualized calcium replacement, CRRT fluid composition, and operational parameters are coordinated to optimize circuit anticoagulation while maintaining electrolyte and acid-base homeostasis. Prescription adjustment should focus on four recurring clinical scenarios: inadequate circuit anticoagulation, negative calcium balance, excessive bicarbonate generation from citrate metabolism, and impaired citrate metabolism. Standardized protocols, structured monitoring, staff training, and workflow integration remain central to safe RCA implementation.

Current Opinion in Critical Care
University of Michigan (US), University of Alabama at Birmingham (US)
Good health and well-being
Openalex Percentile: Top 11%
Acute Kidney Injury Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.